Patient-derived-organoid (PDO) Guided Versus Conventional Therapy for Advanced Inoperable Abdominal Tumors
NCT05378048
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
OTHER
Sponsor class
Stopped
no funding support
Conditions
Organoids
Interventions
DRUG:
PDO-guided treatment
DRUG:
standard of care
Sponsor
Chinese University of Hong Kong